Overview
Julia Scarisbrick practices practicing medicine in Birmingham, United Kingdom.
Ms. Scarisbrick is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), Sezary Syndrome, Mycosis Fungoides, T-Cell Lymphoma, and Bone Marrow Transplant.
She is actively involved in clinical research, co-authoring 88 peer reviewed articles and participating in 4 clinical trials.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Frequently Asked Questions about Julia J. Scarisbrick
Is Julia J. Scarisbrick a top-rated expert for Cutaneous T-Cell Lymphoma (CTCL)?
MediFind is an objective health platform that identifies experts based on real-world data. Julia J. Scarisbrick is classified as an Elite expert for Cutaneous T-Cell Lymphoma (CTCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Julia J. Scarisbrick participate in research or clinical trials?
Yes. Julia J. Scarisbrick has published 88 articles and abstracts on conditions like Cutaneous T-Cell Lymphoma (CTCL). You can view a list of Julia J. Scarisbrick's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Cutaneous T-Cell Lymphoma (CTCL)Ms. Scarisbrick isElite. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Mycosis FungoidesMs. Scarisbrick isElite. Learn about Mycosis Fungoides.
- Non-Hodgkin LymphomaMs. Scarisbrick isElite. Learn about Non-Hodgkin Lymphoma.
- Sezary SyndromeMs. Scarisbrick isElite. Learn about Sezary Syndrome.
- T-Cell LymphomaMs. Scarisbrick isElite. Learn about T-Cell Lymphoma.
- Advanced
- Chronic Graft Versus Host Disease (cGvHD)Ms. Scarisbrick isAdvanced. Learn about Chronic Graft Versus Host Disease (cGvHD).
- Lymphofollicular HyperplasiaMs. Scarisbrick isAdvanced. Learn about Lymphofollicular Hyperplasia.
- Lymphomatoid PapulosisMs. Scarisbrick isAdvanced. Learn about Lymphomatoid Papulosis.
- Experienced
- Anaplastic Large Cell LymphomaMs. Scarisbrick isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Bone Marrow TransplantMs. Scarisbrick isExperienced. Learn about Bone Marrow Transplant.
- Follicular LymphomaMs. Scarisbrick isExperienced. Learn about Follicular Lymphoma.
- Graft Versus Host Disease (GvHD)Ms. Scarisbrick isExperienced. Learn about Graft Versus Host Disease (GvHD).
- Molluscum ContagiosumMs. Scarisbrick isExperienced. Learn about Molluscum Contagiosum.
- ParapsoriasisMs. Scarisbrick isExperienced. Learn about Parapsoriasis.
- Pityriasis LichenoidesMs. Scarisbrick isExperienced. Learn about Pityriasis Lichenoides.
- Pityriasis Lichenoides ChronicaMs. Scarisbrick isExperienced. Learn about Pityriasis Lichenoides Chronica.
- Pityriasis Lichenoides Et Varioliformis AcutaMs. Scarisbrick isExperienced. Learn about Pityriasis Lichenoides Et Varioliformis Acuta.